4.5 Article

Glutamate receptor, metabotropic 7 (GRM7) gene variations and susceptibility to autism: A case-control study

期刊

AUTISM RESEARCH
卷 9, 期 11, 页码 1161-1168

出版社

WILEY
DOI: 10.1002/aur.1640

关键词

autism spectrum disorders; metabotropic glutamate receptor; glutamatergic; polymorphism; GRM7

资金

  1. department of medical genetics of Shahid Beheshti University of medical science of Iran

向作者/读者索取更多资源

Autism spectrum disorder (ASD) as a synaptopathy is revealed to be pertained to aberrant glutamatergic neurotransmission. Glutamate receptor, metabotropic 7 (GRM7), a receptor coding gene of this pathway, is a new candidate gene for autism. The aim of this study was to examine if there is a relationship between genetic variants rs779867 and rs6782011 of GRM7 with ASD. The present research was designed as a population-based, case-control study including 518 ASD patients versus 472 control individuals. The results showed that the frequency of rs779867 G/G genotype was significantly higher in ASD patients compared to healthy controls (P=0.0001). Also, the G allele of this SNP was found to be significantly more frequent in the patients than control group (P=0.0001). Haplotype analysis exhibited significant association of two estimated block of rs6782011/rs779867 in ASD patients versus control group. We found higher significant frequency of GT haplotype and lower frequencies of AT and AC haplotypes in the patients group compared to healthy controls (P=0.001, P=0.006, and P=0.05, respectively). Our study indicated that the rs779867 polymorphism is associated with ASD; thus, results of this study provide supportive evidence of association of the GRM7 gene with ASD. Autism Res2016, 9: 1161-1168. (c) 2016 International Society for Autism Research, Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Correlated downregulation of VDR and CYP3A4 in colorectal cancer

Hossein Sadeghi, Veys Hashemnia, Ehsan Nazemalhosseini-Mojarad, Mohammad Reza Ghasemi, Reza Mirfakhraie

Summary: Experimental studies suggest that vitamin D has tumor-suppressive effects by controlling differentiation, proliferation, and apoptosis in cancer cells. This study investigated the expression level of vitamin D metabolic pathway genes in colorectal cancer (CRC) samples and found that CYP3A4 and VDR genes were significantly downregulated in CRC tissues compared to adjacent tissues. Additionally, a positive correlation was observed between the expression of CYP3A4 and VDR genes. ROC curve analysis revealed the potential diagnostic power of these genes in CRC samples.

MOLECULAR BIOLOGY REPORTS (2023)

Article Endocrinology & Metabolism

Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT)

Jalal Gharesouran, Hassan Hosseinzadeh, Ali Naghiloo, Soudeh Ghafouri-Fard, Bashdar Mahmud Hussen, Mohammad Taheri, Maryam Rezazadeh, Mohammad Samadian

Summary: This study reports a case of CMT, a hereditary neuropathy, in which the patient developed symptoms late in life. A novel 4074 bp homozygote deletion in the MPZ gene was identified through exome sequencing. The study suggests the presence of another protein in peripheral nervous system myelin biogenesis to compensate for the lack of MPZ protein.

METABOLIC BRAIN DISEASE (2023)

Review Neurosciences

A Review on the Role of Genetic Mutations in the Autism Spectrum Disorder

Soudeh Ghafouri-Fard, Ashkan Pourtavakoli, Bashdar Mahmud Hussen, Mohammad Taheri, Seyed Abdulmajid Ayatollahi

Summary: Autism spectrum disorder (ASD) is a common neurodevelopmental disease, affecting approximately 1 in 59 individuals. The disorder is genetically heterogeneous, with both inheritable and de novo mutations in several genes playing a role. The review discusses the different types of mutations, including missense and nonsense mutations, as well as copy number variations, found in individuals affected by ASD.

MOLECULAR NEUROBIOLOGY (2023)

Review Pathology

Dysregulation of non-coding RNAs in Wilms tumor

Mohammad Taheri, Bashdar Mahmud Hussen, Snur Rasool Abdullah, Soudeh Ghafouri-Fard, Elena Jamali, Seyedpouzhia Shojaei

Summary: Wilms tumor, the most common pediatric kidney tumor, is associated with dysregulation of non-coding RNAs. Dysregulated miRNAs such as miR-200c, miR-155-5p, miR-1180, miR-22-3p, miR-483-5p, miR-140-5p, miR-92a-3p, miR-483-3p, miR-572, miR-539, and miR-613, as well as dysregulated long non-coding RNAs including CRNDE, XIST, SNHG6, MEG3, LINC00667, MEG8, DLGAP1-AS2, and SOX21-AS1, have been identified in this tumor. Additionally, circCDYL is down-regulated, while circ0093740 and circSLC7A6 are up-regulated in Wilms tumor. These dysregulated transcripts offer new insights into understanding the pathogenesis and developing targeted therapies for this pediatric tumor.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

Deciphering the role of Hippo pathway in lung cancer

Soudeh Ghafouri-Fard, Yadollah Poornajaf, Bashdar Mahmud Hussen, Shiva Tavakkoli Avval, Mohammad Taheri, Majid Mokhtari

Summary: The Hippo pathway plays a crucial role in regulating organ size, homeostasis, and tumorigenesis. It is involved in lung carcinogenesis through various mechanisms, including the interaction between miRNAs and the Hippo pathway. Non-coding RNAs such as PVT1, SFTA1P, NSCLCAT1, and circ_0067741 are also implicated in this process. Furthermore, several anti-cancer agents can modulate the Hippo pathway to exert their anti-cancer effects in lung cancer. This article summarizes recent studies on the role of Hippo signaling in lung cancer progression, the impact of non-coding RNAs on this pathway, and the effects of anti-cancer agents.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Endocrinology & Metabolism

Expression analysis of inhibitory B7 family members in Alzheimer's disease

Hani Sabaie, Parham Tamimi, Jalal Gharesouran, Zoha Salkhordeh, Mohammad Reza Asadi, Mirmohsen Sharifi-Bonab, Zeinab Shirvani-Farsani, Mohammad Taheri, Arezou Sayad, Maryam Rezazadeh

Summary: Alzheimer's disease (AD) is a complex global health problem, and new methodologies are needed to investigate its pathophysiology and develop treatments. The interaction of immune modulation and neurodegeneration offers potential for discovering biomarkers and therapies. In this study, we compared the expression levels of inhibitory B7 family members in the blood of AD patients and healthy individuals, and found that certain members were significantly higher in patients. These findings suggest the potential of these molecules as diagnostic biomarkers for AD.

METABOLIC BRAIN DISEASE (2023)

Article Endocrinology & Metabolism

Associations between GRM7 polymorphisms and obesity in patients selected for sleeve gastrectomy

Soudeh Ghafouri-Fard, Sara Ahmadi Teshnizi, Shahryar Azizi, Solat Eslami, Mohammad Taheri, Fariborz Rashnoo

Summary: Obesity is a global problem influenced by genetic factors. The study found an association between the GRM7 gene and obesity.

METABOLIC BRAIN DISEASE (2023)

Article Pathology

Expression pattern of lncRNAs in pituitary adenomas

Soudeh Ghafouri-Fard, Maryam Khaledabadi, Ghazal Najafi, Arash Safarzadeh, Bashdar Mahmud Hussen, Solat Eslami, Guive Sharifi, Mohammad Taheri, Nader Akbari Dilmaghani

Summary: This study evaluated the expression of 5 long non-coding RNAs (lncRNAs) in non-functioning pituitary adenomas (NFPAs) and found that the expression of ATP6V0E2-AS1, EPB41L4A-AS1, FGD5-AS1, and WWC2-AS2 was significantly increased in NFPAs. However, the expression of ARHGAP5-AS1 did not differ. Additionally, there were significant positive associations between age of NFPA patients and invasiveness of NFPA, diseases duration and CSF leak, as well as tumor size and Knosp classification and invasiveness of NFPA. This study provides valuable information on lncRNA dysregulation in NFPAs and calls for further research in this field.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas

Soudeh Ghafouri-Fard, Farzaneh Abbasi, Amir Nicknam, Bashdar Mahmud Hussen, Solat Eslami, Nader Akbari Dilmaghani, Mohammad Taheri, Guive Sharifi

Summary: Pituitary adenomas are slow-growing tumors with dysregulation of lncRNAs, including PVT1 and NEAT1, which play important roles in regulating cell functions. In this study, higher expression levels of NEAT1 were found in pituitary adenoma tissues, especially non-functioning pituitary adenoma samples. However, the sensitivity values and AUC values of PVT1 and NEAT1 were not adequate for distinguishing non-functioning pituitary adenomas from non-cancerous tissues.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Review Pathology

Expression of LINC00174 in different cancers: Review of the literature and bioinformatics analyses

Soudeh Ghafouri-Fard, Arash Safarzadeh, Bashdar Mahmud Hussen, Mohammad Taheri, Ahmad Eghbali

Summary: LINC00174 is a long intergenic non-coding RNA that plays important roles in human cancer development. It has been shown to have oncogenic effects in various cancers, including colorectal carcinoma, thymic carcinoma, glioma, glioblastoma, hepatocellular carcinoma, kidney renal clear cell carcinoma, breast cancer, and non-functioning pituitary adenoma. However, the role of LINC00174 in lung cancer remains uncertain. This lincRNA is also involved in determining the prognosis of different cancers, particularly colorectal cancer. In this review, we discuss the role of LINC00174 in human carcinogenesis based on available literature and bioinformatics tools.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Review Pathology

Circular RNAs and inflammation: Epigenetic regulators with diagnostic role

Soudeh Ghafouri-Fard, Hamed Shoorei, Toofan Sabernia, Bashdar Mahmud Hussen, Mohammad Taheri, Hasan Pourmoshtagh

Summary: CircRNAs play an important role in immune-related disorders by regulating immune system function and contributing to pathophysiology.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

Nanoparticle-mediated delivery of microRNAs-based therapies for treatment of disorders

Soudeh Ghafouri-Fard, Hamed Shoorei, Leili Noferesti, Bashdar Mahmud Hussen, Mohammad Hossein Behzad Moghadam, Mohammad Taheri, Fariborz Rashnoo

Summary: miRNA-loaded nanoparticles have been used for the treatment of various disorders, particularly cancers, ischemic stroke, and pulmonary fibrosis. The wide range application of this type of therapy is based on the important roles of miRNAs in regulating cell behavior. The ability of miRNAs to inhibit or increase gene expression gives them an advantage over other therapies.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

Construction of ceRNA network and identification of hub differentially expressed genes associated with breast cancer using reanalysis of microarray dataset: A systems biology approach

Lina Moallemi Rad, Arash Safarzadeh, Mohammad Taheri, Soudeh Ghafouri-Fard, Ahmad Eghbali

Summary: In this study, an in-silico approach was developed to identify the RNA network in breast cancer, which revealed differentially expressed mRNAs, lncRNAs, and miRNAs. Pathway analysis indicated the involvement of various pathways in breast cancer. Furthermore, a ceRNA network consisting of lncRNAs, mRNAs, and miRNAs was constructed, suggesting its potential as a target for anti-cancer therapy and identification of novel markers for breast cancer.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Review Biochemistry & Molecular Biology

The interaction between miRNAs and hazardous materials

Soudeh Ghafouri-Fard, Hamed Shoorei, Shahram Dabiri Oskuei, Bashdar Mahmud Hussen, Snur Rasool Abdullah, Mohammad Taheri, Elena Jamali

Summary: Toxic agents exist widely in the environment, households, and workplaces. Their contamination in food and drinking water leads to their entry into the body, where they interact with microRNAs (miRNAs), influencing the etiology of various disorders. These agents can alter redox status, release inflammatory cytokines, and affect mitochondrial function. Dysregulation of miRNA expression is implicated in the development of pathological conditions and signaling pathways, while also playing a role in environmental adaptation. Therefore, the interactions between miRNAs and toxic materials contribute to the detrimental effects on human health.

NON-CODING RNA RESEARCH (2023)

Review Oncology

Role of miR-424 in the carcinogenesis

Soudeh Ghafouri-Fard, Arian Askari, Bashdar Mahmud Hussen, Mohammad Taheri, Nader Akbari Dilmaghani

Summary: miR-424 is a miRNA involved in the carcinogenic process, with its expression being found to be up-regulated or down-regulated in various cancers. Its expression is regulated by the methylation status of its promoter, and it is also regulated by several long non-coding RNAs. Additionally, miR-424 is involved in the regulation of E2F transcription factors. This review aims to summarize the role of miR-424 in cancer evolution and its impact on clinical outcomes, in order to identify potential markers for malignancies.

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

暂无数据